You just read:

Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression

News provided by

Relmada Therapeutics, Inc.

27 Jun, 2016, 08:30 ET